, Tracking Stock Market Picks
Enter Symbol:
Ligand Pharmaceuticals Incorporated (LGND) [hlAlert]

up 461.01 %

Ligand Pharmaceuticals Incorporated (LGND) rated Buy with price target $6 by Broadpoint Capital

Posted on: Monday,  Jun 23, 2008  8:25 AM ET by Broadpoint Capital

Broadpoint Capital rated Buy Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on 06/23/2008, when the stock price was $16.80. Since
then, Ligand Pharmaceuticals Incorporated has gained 461.01% as of 09/30/2015's recent price of $94.25.
If you would have followed this Broadpoint Capital's recommendation on LGND, you would have gained 461.01% of your investment in 2655 days.

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

Broadpoint Capital, Inc. is an investment banking and capital markets firm that provides corporate and public finance services and trading of corporate, government, and municipal securities for institutions. The company has three divisions: Municipal Capital Markets division, which underwrites and trades municipal securities in new issue and secondary markets; Taxable Fixed Income division, which is a dealer focusing on fixed income securities with limited liquidity; and Equity Capital Markets division, which is a sector-focused investment banking group providing research, trading, raising of capital and advisory services for institutional and corporate clients. Broadpoint Capital, formerly known as First Albany Corporation, was founded in 1953 and is based in New York, New York. The company operates as a subsidiary of First Albany Companies Inc.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/23/2008 8:25 AM Buy
16.80 36.00
as of 12/24/2008
1 Week down  -1.40 %
1 Month up  1.08 %
3 Months up  40.00 %
1 YTD up  2.18 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy